Recently, a decline in MCP1 and RANTES have been attributed to a reduction in visceral fat tissue depots and observed after regular training in patients with metabolic syndrome [44] and obesity [45,46]. This evidence concerns the gene CCL2 and obesity due to melanocortin 4 receptor deficiency.